Home
Overview
Executive Summary
All Strategies
Glossary
About Us
Contact
Download
Search
Please take our 5-question survey!
Narrow Your Results
Strategy
Works
(2)
Gap
(1)
Sections
Women Prisoners and Female Partners of Male Prisoners
(1)
Adherence and Support
(1)
Antenatal Care - Testing and Counseling
(1)
Keywords
pregnancy
(1)
prisoners
(1)
drug treatment
(1)
harm reduction
(1)
needles
(1)
antenatal care
(1)
PMTCT
(1)
HIV testing
(1)
opioids
(1)
Places
Zimbabwe
(1)
Malawi
(1)
Ethiopia
(1)
Kenya
(1)
Uganda
(1)
United States
(1)
Botswana
(1)
Europe
(1)
Iran
(1)
Indonesia
(1)
Ecuador
(1)
Hong Kong
(1)
Gray Ratings
Gray II
(2)
Gray IIIb
(2)
Gray I
(1)
Gray IV
(1)
Gray V
(1)
Showing 1 - 3 of 3 Results for "
Hong Kong
"
Results
Routinely offered testing that is voluntary and accompanied by counseling is acceptable to most women.
Antenatal Care - Testing and Counseling
9 studies
Gray II, IIIb, IV, V
HIV testing, PMTCT, antenatal care, pregnancy
Botswana, Ecuador, Ethiopia, Europe, Hong Kong, Kenya, Malawi, Uganda, United States, Zimbabwe
Interventions are needed to reduce barriers to treatment adherence and to understand how these differ by sex. Increased research is needed to understand the most effective strategies to increase adherence. Studies found that a number of barriers that impact treatment adherence, such as violence, stigma, transport costs, childcare, forced migration, the need for food, the need to hide their medication from their male partners and changes in body image. Screening and treatment for depression may improve adherence, although some studies have shown mixed results. A review found that adherence differs by sex, but with little disaggregation for which factors affect women. Data collection should be more nuanced and not assume that women fall into static groups. A study of people living with HIV who disengaged from ART found that harsh and disrespectful treatment by providers, as well as competing work and livelihood demands, lack of funds for transport, etc. made attendance at ART clinics challenging.
Adherence and Support
1 study
Making opioid agonist treatment available in prisons can be effective in reducing HIV transmission.
Women Prisoners and Female Partners of Male Prisoners
3 studies
Gray I, II, IIIb
drug treatment, harm reduction, needles, opioids, prisoners
Indonesia, Iran
Prevention for Women
Male and Female Condom Use
Partner Reduction
Voluntary Medical Male Circumcision
Treating Sexually Transmitted Infections (STIs)
Treatment as Prevention
Prevention for Key Affected Populations
Female Sex Workers
Women Who Use Drugs and Female Partners of Men Who Use Drugs
Women Prisoners and Female Partners of Male Prisoners
Women and Girls in Complex Emergencies
Migrant Women and Female Partners of Male Migrants
Transgender Women and Men
Women Who Have Sex With Women (WSW)
Prevention and Services for Adolescents and Young People
Mitigating Risk
Increasing Access to Services
HIV Testing and Counseling for Women
Treatment
Provision and Access
Adherence and Support
Staying Healthy and Reducing Transmission
Meeting the Sexual and Reproductive Health Needs of Women Living With HIV
Safe Motherhood and Prevention of Vertical Transmission
Preventing Unintended Pregnancies
Pre-Conception
Antenatal Care - Testing and Counseling
Antenatal Care - Treatment
Delivery
Postpartum
Preventing, Detecting and Treating Critical Co-Infections
Tuberculosis
Malaria
Hepatitis
Strengthening the Enabling Environment
Transforming Gender Norms
Addressing Violence Against Women
Advancing Human Rights and Access to Justice for Women and Girls
Promoting Women’s Employment, Income and Livelihood Opportunities
Advancing Education
Reducing Stigma and Discrimination
Promoting Women’s Leadership
Care and Support
Women and Girls
Orphans and Vulnerable Children
Structuring Health Services to Meet Women’s Needs